Decision Aid for Chemotherapy in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer

The goal of this clinical trial is to investigate the utility and effectiveness of a decision aid in cisplatin-intolerant patients with locally advanced cervical cancer.The main questions it aims to answer are:What is the effectiveness of the decision aid in reducing decisional conflict?What is the utility of the decision aid in preparing for decision-making?Participants will be asked to accomplish the Decisional Conflict Scale before and after using the decision aid.Researchers will compare patients given routine care and the decision aid with patients given routine care to see if the decision aid reduces decisional conflict.

Inclusion Criteria:Squamous, adeno- or adenosquamous histologyInternational Federation of Gynaecology and Obstetrics (FIGO) Stage I-B3, II-A2, II-B to IV-AContraindication to ChT, including but not limited to hydronephrosis, renal or cardiac dysfunction, frailty, or refusalGrade 6 level English literacyInformed consentExclusion Criteria:Other histologiesMetastatic diseaseOther active cancersPrior cancer EXCEPT for a cancer treated curatively, in remission for ≥5 years, with low recurrence risk; adequately treated lentigo maligna or non-melanoma skin cancer without evidence of disease; or adequately treated carcinoma-in-situ without evidence of diseasePrior pelvic radiotherapy, brachytherapy, or chemotherapyPregnancyCognitive impairment or psychological disturbance limiting study compliance